John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Constellium
CSTM
$3.67B
| $877K | ﹤0.01% |
+48,712
| New | +$888K |
|
1752
ACI Worldwide
ACIW
$5.29B
| $875K | ﹤0.01% |
+27,797
| New | +$927K |
|
1753
AXT Inc
AXTI
$4.42B
| $871K | ﹤0.01% |
124,058
+4,472
| +4% | +$33.6K |
|
1754
Cue Biopharma
CUE
$194M
| $863K | ﹤0.01% |
5,892
+4,034
| +217% | +$855K |
|
|
SFT
1755
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $862K | ﹤0.01% |
39,183
-121,347
| -76% | -$2.69M |
|
1756
Carpenter Technology
CRS
$24.1B
| $859K | ﹤0.01% |
20,463
-99,668
| -83% | -$3.49M |
|
|
PFHD
1757
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $857K | ﹤0.01% |
37,969
+6,669
| +21% | +$142K |
|
|
ATCX
1758
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $856K | ﹤0.01% |
+71,116
| New | +$741K |
|
|
MTOR
1759
DELISTED
MERITOR, Inc.
MTOR
| $856K | ﹤0.01% |
+24,060
| New | +$711K |
|
1760
Extreme Networks
EXTR
$2.95B
| $855K | ﹤0.01% |
70,037
-190,200
| -73% | -$2.37M |
|
1761
Titan International
TWI
$464M
| $855K | ﹤0.01% |
58,076
-33,418
| -37% | -$391K |
|
1762
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$376M
| $855K | ﹤0.01% |
+11,390
| New | +$731K |
|
1763
Euroseas
ESEA
$543M
| $854K | ﹤0.01% |
+36,157
| New | +$853K |
|
1764
Equity Bancshares
EQBK
$1.02B
| $852K | ﹤0.01% |
26,368
-10,597
| -29% | -$344K |
|
|
EWCZ
1765
DELISTED
European Wax Center
EWCZ
| $851K | ﹤0.01% |
+28,787
| New | +$749K |
|
1766
Immunic
IMUX
$224M
| $850K | ﹤0.01% |
7,520
-5,426
| -42% | -$628K |
|
1767
Ducommun
DCO
$2.74B
| $847K | ﹤0.01% |
16,163
-51
| -0.3% | -$2.43K |
|
|
RVI
1768
DELISTED
Retail Value Inc. Common Shares
RVI
| $845K | ﹤0.01% |
276,144
-375,535
| -58% | -$1.19M |
|
|
GBIO
1769
DELISTED
Generation Bio
GBIO
| $844K | ﹤0.01% |
11,492
-12,806
| -53% | -$742K |
|
|
SEEL
1770
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $844K | ﹤0.01% |
262
-64
| -20% | -$275K |
|
|
STKL
1771
DELISTED
SunOpta
STKL
| $842K | ﹤0.01% |
167,676
-347,686
| -67% | -$1.83M |
|
|
MOMO
1772
Hello Group
MOMO
$853M
| $841K | ﹤0.01% |
+145,419
| New | +$1.26M |
|
1773
JB Hunt Transport Services
JBHT
$24.6B
| $839K | ﹤0.01% |
+4,177
| New | +$832K |
|
1774
Business First Bancshares
BFST
$1.01B
| $838K | ﹤0.01% |
34,454
+3,501
| +11% | +$93.3K |
|
1775
Peapack-Gladstone Financial
PGC
$800M
| $837K | ﹤0.01% |
24,098
-4,177
| -15% | -$154K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.